|
VPS72 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.638400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.313200E-01 |
| Normal-vs-Stage2 |
2.576400E-01 |
| Normal-vs-Stage3 |
1.595560E-01 |
| Normal-vs-Stage4 |
9.448000E-01 |
| Stage1-vs-Stage2 |
6.086000E-01 |
| Stage1-vs-Stage3 |
3.398600E-03 |
| Stage1-vs-Stage4 |
2.459000E-01 |
| Stage2-vs-Stage3 |
4.210100E-02 |
| Stage2-vs-Stage4 |
2.573400E-01 |
| Stage3-vs-Stage4 |
2.282000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.360400E-01 |
| Normal-vs-AfricanAmerican |
2.476600E-01 |
| Normal-vs-Asian |
3.855600E-01 |
| Caucasian-vs-AfricanAmerican |
2.174400E-01 |
| Caucasian-vs-Asian |
2.566600E-01 |
| AfricanAmerican-vs-Asian |
5.818800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.188800E-01 |
| Normal-vs-Female |
6.418200E-01 |
| Male-vs-Female |
8.655600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.687000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.454600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.567600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.241800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.011800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.508400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.821000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.258000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.063400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.024800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.91344999999066E-05 |
| Normal-vs-Grade 2 |
2.642200E-01 |
| Normal-vs-Grade 3 |
7.133200E-01 |
| Normal-vs-Grade 4 |
1.939360E-01 |
| Grade 1-vs-Grade 2 |
1.035970E-04 |
| Grade 1-vs-Grade 3 |
1.65676999999143E-05 |
| Grade 1-vs-Grade 4 |
8.31950000002024E-07 |
| Grade 2-vs-Grade 3 |
8.051900E-02 |
| Grade 2-vs-Grade 4 |
1.639600E-02 |
| Grade 3-vs-Grade 4 |
2.658000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.306200E-02 |
| Normal-vs-ccB subtype |
7.881600E-02 |
| ccA subtype-vs-ccB subtype |
1.6454899999907E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.859600E-01 |
| Normal-vs-N1 |
4.562000E-01 |
| N0-vs-N1 |
3.192600E-01 |
|
|
